Trial · NCT03214588
Results by group1,122
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 1,122
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in the Inverse Time to Complete the 9-Hole Peg Test (9-HPT-1) | Placebo | 0.00038 | Standard Error 0.000448 | 1/seconds | |
| Change From Baseline in the Inverse Time to Complete the 9-Hole Peg Test (9-HPT-1) | TAK-831 75 mg | -0.00017 | Standard Error 0.000622 | 1/seconds | |
| Change From Baseline in the Inverse Time to Complete the 9-Hole Peg Test (9-HPT-1) | TAK-831 300 mg | -0.00032 | Standard Error 0.000445 | 1/seconds | |
| Change From Baseline in the Activities of Daily Living (ADL) Component Score of the Friedreich Ataxia Rating Scale (FARS) | Placebo | Change from Baseline at Week 2 | -0.25 | Standard Error 0.468 | score on a scale |
| Change From Baseline in the Activities of Daily Living (ADL) Component Score of the Friedreich Ataxia Rating Scale (FARS) | TAK-831 75 mg | Change from Baseline at Week 2 | -1.12 | Standard Error 0.665 | score on a scale |
| Change From Baseline in the Activities of Daily Living (ADL) Component Score of the Friedreich Ataxia Rating Scale (FARS) | TAK-831 300 mg | Change from Baseline at Week 2 | 0.34 | Standard Error 0.463 | score on a scale |
| Change From Baseline in the Activities of Daily Living (ADL) Component Score of the Friedreich Ataxia Rating Scale (FARS) | Placebo | Change from Baseline at Week 7 | -0.33 | Standard Error 0.465 | score on a scale |
| Change From Baseline in the Activities of Daily Living (ADL) Component Score of the Friedreich Ataxia Rating Scale (FARS) | TAK-831 75 mg | Change from Baseline at Week 7 | -0.15 | Standard Error 0.655 | score on a scale |
| Change From Baseline in the Activities of Daily Living (ADL) Component Score of the Friedreich Ataxia Rating Scale (FARS) | TAK-831 300 mg | Change from Baseline at Week 7 | 0.03 | Standard Error 0.467 | score on a scale |
| Change From Baseline in the Activities of Daily Living (ADL) Component Score of the Friedreich Ataxia Rating Scale (FARS) | Placebo | Change from Baseline at Week 12 | -0.61 | Standard Error 0.493 | score on a scale |
| Change From Baseline in the Activities of Daily Living (ADL) Component Score of the Friedreich Ataxia Rating Scale (FARS) | TAK-831 75 mg | Change from Baseline at Week 12 | -0.37 | Standard Error 0.696 | score on a scale |
| Change From Baseline in the Activities of Daily Living (ADL) Component Score of the Friedreich Ataxia Rating Scale (FARS) | TAK-831 300 mg | Change from Baseline at Week 12 | -0.24 | Standard Error 0.488 | score on a scale |
| Change From Baseline in the Inverse Time to Complete the 9-HPT-1 | Placebo | Change from Baseline at Week 2 | 0.00087 | Standard Error 0.000371 | 1/seconds |
| Change From Baseline in the Inverse Time to Complete the 9-HPT-1 | TAK-831 75 mg | Change from Baseline at Week 2 | 0.00048 | Standard Error 0.000508 | 1/seconds |
| Change From Baseline in the Inverse Time to Complete the 9-HPT-1 | TAK-831 300 mg | Change from Baseline at Week 2 | -0.00006 | Standard Error 0.000370 | 1/seconds |
| Change From Baseline in the Inverse Time to Complete the 9-HPT-1 | Placebo | Change from Baseline at Week 7 | 0.00040 | Standard Error 0.000462 | 1/seconds |
| Change From Baseline in the Inverse Time to Complete the 9-HPT-1 | TAK-831 75 mg | Change from Baseline at Week 7 | 0.00026 | Standard Error 0.000643 | 1/seconds |
| Change From Baseline in the Inverse Time to Complete the 9-HPT-1 | TAK-831 300 mg | Change from Baseline at Week 7 | -0.00004 | Standard Error 0.000471 | 1/seconds |
| Change From Baseline in the ADL Component Individual Item Scores | Placebo | Change at Week 2, Speech | 0.07 | Standard Deviation 0.494 | score on a scale |
| Change From Baseline in the ADL Component Individual Item Scores | TAK-831 75 mg | Change at Week 2, Speech | -0.15 | Standard Deviation 0.427 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03214588/results